arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Metagenomi Therapeutics, Inc.

MGX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.82
▼ -1.8% Today
as of Oct 23, 09:20 ET
Last 30 days -31.43% Sep 14 → Oct 22
$0.75 $0.87 $0.99 $1.10 $1.22 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.81
High
$0.84
Low
$0.80
Volume
$54,264
Avg Vol
$236,941
Mkt Cap
$42M
P/E (TTM)
—
Beta
—
52w High
$3.00
52w Low
$0.77
Div Yield
—
Shares Out
$38M

Recent Press Releases & News last 60 days · 2 items

MGX earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.7% on average; after the most recent report on May 11, 2026 it moved -4.3%. MGX beat the consensus EPS estimate in 2 of its last 4 reported quarters. The share price of $0.82 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.77
$3.00
2% of range
Avg surprise (last 4)
+4.4%
Avg reaction (last 2)
-0.5%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-5.82$-4.44$-3.06$-1.67$-0.29 Actual $-4.74Actual $-3.82Actual $-5.82Actual $-1.19Actual $-0.29Actual $-0.51Actual $-0.68Est $-0.62Actual $-0.54Est $-0.68Actual $-0.55Est $-0.60Actual $-0.61Est $-0.60Actual $-0.73 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-27M$-18M$-8M$2M$12M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.73 — — — — financials
Mon May 11, 2026Mar/2026 $-0.61 $-0.60 -1.7% +10.3% -4.3% earnings
Tue Nov 11, 2025Sep/2025 $-0.55 $-0.60 +8.3% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.54 $-0.68 +20.6% — — earnings
Tue May 13, 2025Mar/2025 $-0.68 $-0.62 -9.7% — +3.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.51 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.29 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.19 — — — — financials
Sat Sep 30, 2023Sep 2023 $-5.82 — — — — financials
Fri Jun 30, 2023Jun 2023 $-3.82 — — — — financials
Fri Mar 31, 2023Mar 2023 $-4.74 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue—$1M—$9M$9M$4M—$12M
Cost of revenue————————
Gross profit————————
Operating income$-29M$-25M—$-23M$-21M$-28M—$-22M
Net income$-27M$-23M—$-20M$-20M$-25M—$-19M
EPS (diluted)$-0.73$-0.61—$-0.55$-0.54$-0.68—$-0.51

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$39M$25M$42M$33M$27M$29M$27M$25M
Inventory————————
Total current assets$124M$145M$166M$190M$212M$233M$258M$282M
Total assets$174M$197M$221M$248M$272M$298M$325M$358M
Long-term debt————————
Total liabilities$61M$59M$63M$69M$76M$85M$90M$103M
Total equity$113M$138M$159M$178M$196M$213M$235M$256M

Implied volatility — last 90 days

No IV snapshots yet for MGX.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

MGX earnings FAQ

How does MGX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.7%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.